Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

605789

registered interest
date	19/10/2016
answering body	HM Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	CaTreasury
hansard heading	Minimum Wage
house id	1
legislature	25259 pref label House of Commons
question text	To ask Mr Chancellor of the Exchequer, what assessment he has made of the effect of the increase in the national minimum wage on the incomes of low income households; and if he will make a statement.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	49383
answer	answer is ministerial correction date of answer 27/10/2016 answer text <p>The introduction of the National Living Wage in April 2016 marked an important step towards building an economy that works for everyone. At £7.20, it represented a 50p increase on the National Minimum Wage, and a pay rise for over a million low paid workers across the UK, many of whom will be in low income households.</p><p> </p><p>The estimated impacts of the National Living Wage are set out in the impact assessment and Annex B of the Office of Budget Responsibility’s July Economic and Fiscal Outlook (available at http://www.legislation.gov.uk/ukdsi/2016/9780111141625/impacts/2016/3 and http://budgetresponsibility.org.uk/docs/dlm_uploads/July-2015-EFO-234224.pdf respectively).</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2016 14:01:16 answering member 3918 label Biography information for Jane Ellison
tabling member	3960 label Biography information for Henry Smith

528906

registered interest
date	27/06/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the implications for his policies of the findings of the National Cancer Patient Experience Survey 2015 on the proportion of blood cancer patients who visited their GP more than twice before being referred to secondary care for diagnosis; and what support and guidance his Department has provided to GPs to enable them to identify the symptoms of blood cancer.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	41284
answer	answer is ministerial correction date of answer 05/07/2016 answer text <p>It is important that people with cancer have the best possible experience throughout their cancer pathway and are treated with dignity and respect.</p><p> </p><p>The independent Cancer Taskforce published its report <em>Achieving World-Class Cancer Outcomes – A Strategy for England 2015-2020</em> in July 2015, and identified a key priority of establishing patient experience as being on a par with clinical effectiveness and safety. In May 2016 the National Cancer Transformation Board published <em>Achieving World-Class Cancer Outcomes:</em> <em>Taking the Strategy Forward</em> outlining the detailed steps being taken to make this a reality.</p><p> </p><p>In September 2015, the Government announced that by 2020, the 280,000 people diagnosed with cancer every year will benefit from a tailored recovery package. The packages will be individually designed to help each person, including those with blood cancer, live well beyond cancer. In April 2016 NHS England published guidance for commissioners on commissioning and implementing the recovery package effectively.</p><p> </p><p>In order to continue to support general practitioners (GPs) to identify patients whose symptoms may indicate cancer and urgently refer them as appropriate, the National Institute for Health and Care Excellence (NICE) published an updated suspected cancer referral guideline in June 2015. The guideline includes new recommendations for haematological cancers. NICE noted that more lives could be saved each year in England if GPs followed the new guideline, which encourages GPs to think of cancer sooner and lower the referral threshold. Following publication of the updated guideline, the Royal College of GPs (RCGP) has worked in collaboration with Cancer Research UK (CRUK) on a programme of regional update events for GPs to promote the new guideline. RCGP and CRUK have also worked to develop three summary referral guidelines for GPs to enable them to adopt the guideline. These are available at:</p><p> </p><p><a href="http://www.cancerresearchuk.org/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines" target="_blank">www.cancerresearchuk.org/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines</a></p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 41285 41329 question first answered 05/07/2016 15:11:22 answering member 3918 label Biography information for Jane Ellison
tabling member	3960 label Biography information for Henry Smith

528907

registered interest
date	27/06/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Health Education
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to raise public awareness of blood cancer and other cancers for which symptoms can be non-specific and have similarities to other benign conditions.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	41283
answer	answer is ministerial correction date of answer 05/07/2016 answer text <p>Public Health England’s (PHE) Be Clear on Cancer campaigns are designed to raise the public’s awareness of specific cancer symptoms, encourage people with those symptoms to go to the doctor and diagnose cancer at an earlier stage. These campaigns are delivered by PHE in partnership with the Department and NHS England.</p><p> </p><p>The decision on which cancers should be the focus of ‘Be Clear on Cancer’ campaigns is informed by a steering group, whose members include primary and secondary care clinicians, and key voluntary sector organisations.</p><p> </p><p>A number of factors are taken into account when deciding which campaigns to develop and run, with one of the main criteria being the scope to save lives through earlier diagnosis and whether the cancer has a clear early sign or symptom that the general public can act upon should it arise. There are a number of cancers, including those for which symptoms can be non-specific, which are not covered by ‘Be Clear on Cancer’ specifically.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 05/07/2016 15:10:26 answering member 3918 label Biography information for Jane Ellison
tabling member	3960 label Biography information for Henry Smith

528908

registered interest
date	27/06/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the implications for his policies of the findings of the National Cancer Patient Experience Survey 2015 on the proportion of blood cancer patients that understood the explanation given to them at diagnosis; and if he will take steps to increase support for such patients at the point of diagnosis.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	41285
answer	answer is ministerial correction date of answer 05/07/2016 answer text <p>It is important that people with cancer have the best possible experience throughout their cancer pathway and are treated with dignity and respect.</p><p> </p><p>The independent Cancer Taskforce published its report <em>Achieving World-Class Cancer Outcomes – A Strategy for England 2015-2020</em> in July 2015, and identified a key priority of establishing patient experience as being on a par with clinical effectiveness and safety. In May 2016 the National Cancer Transformation Board published <em>Achieving World-Class Cancer Outcomes:</em> <em>Taking the Strategy Forward</em> outlining the detailed steps being taken to make this a reality.</p><p> </p><p>In September 2015, the Government announced that by 2020, the 280,000 people diagnosed with cancer every year will benefit from a tailored recovery package. The packages will be individually designed to help each person, including those with blood cancer, live well beyond cancer. In April 2016 NHS England published guidance for commissioners on commissioning and implementing the recovery package effectively.</p><p> </p><p>In order to continue to support general practitioners (GPs) to identify patients whose symptoms may indicate cancer and urgently refer them as appropriate, the National Institute for Health and Care Excellence (NICE) published an updated suspected cancer referral guideline in June 2015. The guideline includes new recommendations for haematological cancers. NICE noted that more lives could be saved each year in England if GPs followed the new guideline, which encourages GPs to think of cancer sooner and lower the referral threshold. Following publication of the updated guideline, the Royal College of GPs (RCGP) has worked in collaboration with Cancer Research UK (CRUK) on a programme of regional update events for GPs to promote the new guideline. RCGP and CRUK have also worked to develop three summary referral guidelines for GPs to enable them to adopt the guideline. These are available at:</p><p> </p><p><a href="http://www.cancerresearchuk.org/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines" target="_blank">www.cancerresearchuk.org/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines</a></p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 41284 41329 question first answered 05/07/2016 15:11:22 answering member 3918 label Biography information for Jane Ellison
tabling member	3960 label Biography information for Henry Smith

528917

registered interest
date	27/06/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he has taken to adapt the cancer recovery package and investigate new models of care for blood cancer patients who are (a) given treatment and (b) put on a watch and wait regime after diagnosis.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	41329
answer	answer is ministerial correction date of answer 05/07/2016 answer text <p>It is important that people with cancer have the best possible experience throughout their cancer pathway and are treated with dignity and respect.</p><p> </p><p>The independent Cancer Taskforce published its report <em>Achieving World-Class Cancer Outcomes – A Strategy for England 2015-2020</em> in July 2015, and identified a key priority of establishing patient experience as being on a par with clinical effectiveness and safety. In May 2016 the National Cancer Transformation Board published <em>Achieving World-Class Cancer Outcomes:</em> <em>Taking the Strategy Forward</em> outlining the detailed steps being taken to make this a reality.</p><p> </p><p>In September 2015, the Government announced that by 2020, the 280,000 people diagnosed with cancer every year will benefit from a tailored recovery package. The packages will be individually designed to help each person, including those with blood cancer, live well beyond cancer. In April 2016 NHS England published guidance for commissioners on commissioning and implementing the recovery package effectively.</p><p> </p><p>In order to continue to support general practitioners (GPs) to identify patients whose symptoms may indicate cancer and urgently refer them as appropriate, the National Institute for Health and Care Excellence (NICE) published an updated suspected cancer referral guideline in June 2015. The guideline includes new recommendations for haematological cancers. NICE noted that more lives could be saved each year in England if GPs followed the new guideline, which encourages GPs to think of cancer sooner and lower the referral threshold. Following publication of the updated guideline, the Royal College of GPs (RCGP) has worked in collaboration with Cancer Research UK (CRUK) on a programme of regional update events for GPs to promote the new guideline. RCGP and CRUK have also worked to develop three summary referral guidelines for GPs to enable them to adopt the guideline. These are available at:</p><p> </p><p><a href="http://www.cancerresearchuk.org/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines" target="_blank">www.cancerresearchuk.org/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines</a></p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 41284 41285 question first answered 05/07/2016 15:11:22 answering member 3918 label Biography information for Jane Ellison
tabling member	3960 label Biography information for Henry Smith

433989

registered interest
date	03/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to raise public awareness of multiple myeloma and the risks presented by late diagnosis of acute myeloid leukaemia.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	18669
answer	answer is ministerial correction date of answer 11/12/2015 answer text <p>Public Health England’s ‘Be Clear on Cancer’ campaigns do not currently include multiple myeloma.</p><br /><p>A number of factors are taken into account when deciding which campaigns to develop and run, with one of the main criteria being the scope to save lives through earlier diagnosis and whether the cancer has a clear early sign or symptom that the general public can act upon should it arise.</p><br /><p>We appreciate that this means that there are a number of cancers, besides Myeloid Leukaemia, that are not covered by ‘Be Clear on Cancer’ specifically. Given this, Public Health England is looking at developing an approach to raise awareness of generic symptoms that can indicate a wider number of cancers and the need to visit the doctor promptly with these symptoms. This work is currently in development, with the help of a number of experts, including clinicians and charities.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 11/12/2015 11:47:28 answering member 3918 label Biography information for Jane Ellison
tabling member	3960 label Biography information for Henry Smith

433998

registered interest
date	03/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Multiple Myeloma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether an assessment has been made of the barriers preventing multiple myeloma patients accessing the most innovative treatments.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	18708
answer	answer is ministerial correction date of answer 11/12/2015 answer text <p>No specific assessment has been made of the barriers affecting access to the most innovative treatments for patients with multiple myeloma.</p><br /><p>It is essential that a robust process is in place to ensure that patients get rapid access to the most innovative drugs that represent value for money to the National Health Service. The Cancer Drugs Fund has helped over 84,000 people to access the life-extending drugs they need, and NHS England and the National Institute for Health and Care Excellence are currently consulting on the future shape of the Fund to put it on a more sustainable footing.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 11/12/2015 12:18:24 answering member 3918 label Biography information for Jane Ellison
tabling member	3960 label Biography information for Henry Smith

427717

registered interest
date	10/11/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Leukaemia: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what comparative assessment his Department has made of the (a) cost and (b) effectiveness of stem cell transplants and tyrosine kinase inhibitor therapies as treatments for chronic myeloid leukaemia.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	15807
answer	answer is ministerial correction date of answer 19/11/2015 answer text <p>As the treatments referred to are mutually exclusive, NHS England has no plans to carry out such an assessment. Patients will only be offered a transplant when they are unsuitable for tyrosine kinase inhibitor (TKI) treatment, or if this treatment has failed.</p><br /><p>Both imatinib (usually considered the first line option) and nilotinib are recommended by the National Institute for Health and Care Excellence as cost effective treatments for chronic myeloid leukaemia (CML). Dasatinib, bosutinib and ponatinib are only available for certain patients through the Cancer Drugs Fund.</p><p>In 2013, NHS England published a policy for the routine commissioning of allogeneic stem cell transplant for CML. This can be found at:</p><br /><p><a href="http://www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2015/01/b04-haematp-stem-cll-transplt.pdf" target="_blank">www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2015/01/b04-haematp-stem-cll-transplt.pdf</a></p><p>This policy allows for transplant in patients whose CML is refractory to TKI treatment, or where the patient is TKI intolerant. It takes into account expert advice from the British Society for Blood and Marrow Transplantation.</p><p>Based on the clinical pathway of care, no specific assessment of cost or effectiveness comparing blood and marrow transplantation with TKI has been undertaken.</p><br /><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p> answering member constituency Battersea answering member printed Jane Ellison question first answered 19/11/2015 17:31:59 answering member 3918 label Biography information for Jane Ellison
tabling member	3960 label Biography information for Henry Smith

419533

registered interest
date	17/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Urinary System: Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many catheter associated urinary tract infection related deaths there were in the last three years.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	10618
answer	answer is ministerial correction date of answer 12/10/2015 answer text <p>This information is not available in the format requested.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 12/10/2015 10:57:21 answering member 3918 label Biography information for Jane Ellison
tabling member	3960 label Biography information for Henry Smith

419535

registered interest
date	17/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Urinary System: Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people were admitted to hospital as an emergency case with acute retention of urine due to a blocked Foley catheter in the last three years.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	10620
answer	answer is ministerial correction date of answer 12/10/2015 answer text <p>The requested information is not available centrally as Hospital Episode Statistics cannot identify blocked catheters or the type of catheter in use.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 12/10/2015 10:58:44 answering member 3918 label Biography information for Jane Ellison
tabling member	3960 label Biography information for Henry Smith